BioAge Labs (BIOA) Profit After Tax (2023 - 2026)
BioAge Labs' (BIOA) quarterly Profit After Tax came in at -$22.3 million in Q1 2026, down 72.13% year-on-year from -$79.8 million in Q1 2025, and up 14.22% quarter-over-quarter from -$25.9 million in Q4 2025.
BioAge Labs (BIOA) Profit After Tax (2023 - 2026) Analysis & Trends
BioAge Labs has disclosed Profit After Tax across 4 years of filings, most recently posting -$22.3 million for Q1 2026.
- Profit After Tax for Q1 2026 came in at -$22.3 million, down 72.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$89.9 million (down 26.58% YoY), and the FY2025 annual result was -$80.6 million, down 13.35% from the prior year.
- Profit After Tax came in at -$22.3 million for Q1 2026 at BioAge Labs, up from -$25.9 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$12.9 million in Q1 2025 to a low of -$25.9 million in Q4 2025.
- The 4-year median for Profit After Tax is -$21.0 million (2023), against an average of -$19.0 million.
- Across the five-year window, Profit After Tax gained 13.82% in 2025 and slumped 72.13% in 2026, its largest moves.
- BioAge Labs' Profit After Tax stood at -$21.0 million in 2023, then decreased by 0.82% to -$21.1 million in 2024, then slipped by 22.78% to -$25.9 million in 2025, then advanced by 14.22% to -$22.3 million in 2026.
- The last three Profit After Tax figures came in at -$22.3 million (Q1 2026), -$25.9 million (Q4 2025), and -$20.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 369.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 197.90 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 11.81 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 16.20 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 52.86 Mn |
| 10 | BioAge Labs | 765.07 Mn | 381.88 Mn | -10.37 Mn | -22.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.25 Mn |
| Dec 31, 2025 | -25.94 Mn |
| Sep 30, 2025 | -20.17 Mn |
| Jun 30, 2025 | -21.56 Mn |
| Mar 31, 2025 | -12.93 Mn |
| Dec 31, 2024 | -21.13 Mn |
| Sep 30, 2024 | -23.41 Mn |
| Jun 30, 2024 | -13.58 Mn |
| Mar 31, 2024 | -12.99 Mn |
| Dec 31, 2023 | -20.96 Mn |
| Sep 30, 2023 | -14.63 Mn |